Related Experiment Video
Updated: May 10, 2025

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Cryptococcus neoformans in Chronic Lymphocytic Leukemia (CLL) Treated With Ibrutinib: A Combo Gone Wrong!
Yogesh Yadav1, Felipe Centellas Montano1, Elizabeth Plocharczyk2
1Internal Medicine, Cayuga Medical Center, Ithaca, USA.
This case report details a rare complication of cryptococcal disease in a patient treated with ibrutinib for chronic lymphocytic leukemia (CLL). Early diagnosis and multidisciplinary care were crucial for managing this serious fungal infection.
Area of Science:
- Oncology
- Infectious Diseases
- Pulmonology
Background:
- Chronic lymphocytic leukemia (CLL) is a hematologic malignancy often treated with targeted therapies.
- Ibrutinib is a Bruton's tyrosine kinase inhibitor used in CLL treatment, which can increase the risk of infections.
- Fungal infections, particularly cryptococcosis, can be severe in immunocompromised patients.
More Related Videos
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019